
Evaluation and Management of Cerebral Vasospasm after Subarachnoid Hemorrhage
Author(s) -
Hani Mohammed Alabdaly,
Othman Mohammad Alassaf,
Danah kamal kabrah,
Khaled Bassam A. Almadi,
Renda Ali Alhabib,
Rakan M. Alotaibi,
Abdullah S. Almalki,
Fahad Azib Alghamdi,
Reema Abdullah H Albalawi,
Laila Hamad Hakami,
Moudhi Mohammed Alajmi
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i60b34645
Subject(s) - medicine , subarachnoid hemorrhage , vasospasm , cerebral vasospasm , transcranial doppler , cardiology , anesthesia , ischemia
Constriction of the large and medium-sized cerebral arteries following an aneurysmal subarachnoid haemorrhage (aSAH) is a well-known condition that primarily affects the anterior circulation supplied by the internal carotid arteries. SAH is a rare but potentially fatal type of stroke. Across the literature, authors have defined vasospasm using terms such as "symptomatic vasospasm," "delayed cerebral ischemia" (DCI), "transcranial Doppler vasospasm," and "angiographic vasospasm." Because posthemorrhagic vasospasm causes significant neurologic morbidity and death, there has been a great deal of interest and research into its physiologic basis and developing effective preventative and treatment strategies. The triple-H therapy hemodynamic augmentation technique, which includes hypertension, hemodilution, and hypervolemia, has been an important part of the treatment. In this article, we'll look at cerebral vasospasm following subarachnoid haemorrhage, including its causes, epidemiology, evaluation, and, most importantly, management.